Craig Muir, Partner and Chief Technology Officer at Third Rock Ventures, Boston, Massachusetts. See sector focus and contact routes.
Third Rock Ventures discovers, launches, builds, and transforms companies. They have 73 portfolio companies and 26 marketed products, focusing on areas such as oncology (Tango Therapeutics, Synnovation Therapeutics, INLEXZO, Azalea Therapeutics), genetic hearing loss (Otarmeni), anemia (Aqvesme), mental health (Syremis Therapeutics), cardiovascular health (Element Science), and antibody-driven diseases (Merida Biosciences). They operate from Boston, MA, and San Francisco, CA.
StartupFundraising tracks this investor record from SEC filings and announced rounds, updating focus, location and portfolio history as new data lands. Use it to gauge fit before an outreach, then widen the search to investors in Boston.
Investors like Craig Muir · Full investor directory · Investor access · Company funding database